Lilly’s $400 Billion Surge Reshapes Big Pharma, Rally
Eli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
Plan a withdrawal strategy post-rebalancing for SP 500 holdings to sustain income while managing risk.
24,074 articlesEli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
As oil markets shift, offshore drilling and onshore completion services offer different paths to profits. This compar...
Tesla's robotaxi just launched in Miami, marking a milestone for autonomous transport. Yet the pilot comes with a del...
SoundHound AI aims to own the voice layer that connects users to services. This article builds a practical bull case ...
Flat home prices “mirror” a familiar 1990s pattern, signaling subtle shifts for buyers and investors. This article un...
Investors woke to a drop in first majestic silver stock as metal prices wavered and costs rose. This guide breaks dow...
AI's energy appetite is growing. This article explains how these energy stocks helping power AI’s rise and what it me...
Global dividend payments in Q3 2025 surged to a record, signaling the largest dividend payout history and fueling ren...
General Mills is down 20% this year as executives double down on value promotions to win back budget-conscious shoppe...
When a pop star challenges a political use of her music, the ripple effects reach far beyond headlines. This analysis...
Is SoFi Technologies stock your path to wealth? This guide weighs growth potential, risks, and practical steps to hel...
As mega-cap tech pours capital into AI, investors seek signs of durable returns. This piece analyzes which firms stan...